CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for EVOQ Remedies Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

EVOQ Remedies Ltd
Phone: +91 7948402525p:+91 7948402525 AHMEDABAD, 380060  India Ticker: 543500543500
Business Summary
EVOQ Remedies Limited is an India-based company, which is a manufacturer and supplier of pharmaceutical products. The Company is engaged in the pharmaceutical business involving marketing, trading, and distribution of a range of pharmaceutical formulation products, such as antibiotic drugs, anti-malarial drugs, anti-allergic and cold drugs, analgesic/antipyretic and anti-inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastrointestinal drugs, steroids, gynecology drugs, calcium, multivitamins, antioxidants, and injections. It offers a range of pharmaceutical formulation products, of which around 120 products are marketed by the Company under its own brand name. It also deals in the trading of active pharmaceutical ingredients (APIs). Its products include Abacavir Sulphate, Acetazolamide, Acyclovir, Adefovir Dipivoxil Allylestrenole, Alpha Beta Arteether, Alpha Lipoic Acid, Alprazolam , Amoxycillin Trihydrate, Ampicillin Trihydrate, and more.
(Source: 10-K405)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/20243/31/2024-----

Industries
SIC Code Description
2834 Pharmaceutical preparations
5122 Drugs, drug proprietaries, and druggists' sundries

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Financial Officer YogeshRajput 2/12/2022 2/12/2022
Company Secretary, Compliance Officer GitikaMishra 2/3/2024 2/3/2024
Managing Director, Director Bhumishth N.Patel
3 additional Officers and Directors records available in full report.

Business Names
Business Name
5435
543500

General Information
Outstanding Shares: 24,900,000 (As of 6/22/2024)
Stock Exchange: BOM
Email Address: info@evoqremedies.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024